Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology (Internal Medicine) Physician in Columbus, OH
NPI: 1003862236Primary Practice Location
OHIO STATE UNIVERSITY STATE HEALTH SYSTEM
1670 Upham Dr, Columbus, OH
Primary Employer
OSU Internal Medicine
wexnermedical.osu.edu
HQ Phone
Get M.D. Don's Phone Numberphone_androidMobile
Get M.D. Don's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
OH State Medical License
2003 - 2027
VA State Medical License
1999 - 2004
American Board of Internal Medicine
Medical Oncology
Ohio State University Hospital
Fellowship • Hematology and Medical Oncology
2003 - 2006
University of Virginia Medical Center
Residency • Internal Medicine
1999 - 2003
Northeast Ohio Medical University
neomed.edu
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 187 | 249 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 107 | 158 |
| 3 | 99441Physician telephone patient service, 5-10 minutes of medical discussion | 11 | 13 |
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.
Authors: John Byrd, James Blachly, Sumithira Vasu, William Carson
Publication Date: 2016-08-10
Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up.
Authors: Nidhi Sharma, Ashley Rosko, Yvonne Efebera, Srinivas Devarakonda, Naresh Bumma
Publication Date: 2019-07-24
Authors: Nidhi Sharma, Ashley Rosko, Srinivas Devarakonda, Elvira Umyarova, Naresh Bumma
Journal: Front Oncol
Publication Date: 2023-07-24
Lead Sponsor: NexImmune Inc.
Intervention / Treatment: BIOLOGICAL: Infusion of NEXI-001 T Cells
Lead Sponsor: Cogent Biosciences, Inc.
Collaborators: Seagen Inc.
Intervention / Treatment: BIOLOGICAL: SEA-BCMA, BIOLOGICAL: ACTR087
Lead Sponsor: Takeda
Intervention / Treatment: DRUG: Dexamethasone, DRUG: Modakafusp alfa
